In vitro and in vivo activities of pterostilbene against Candida albicans biofilms

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 4, 2014, Pages 2344-2355

  Li, De Dong ^a,b   Zhao, Lan Xue ^a,c   Mylonakis, Eleftherios ^b   Hu, Gan Hai ^a   Zou, Yong ^d   Huang, Tong Kun ^d   Yan, Lan ^a   Wang, Yan ^a   Jiang, Yuan Ying ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b BROWN UNIVERSITY   (United States)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d GUANGZHOU INSTITUTE OF CHEMISTRY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; ASPARTIC PROTEINASE; CYCLIC AMP; ERGOSTEROL; FLUCONAZOLE; GUANOSINE TRIPHOSPHATASE; METHIONINE ADENOSYLTRANSFERASE; OXIDOREDUCTASE; PTEROSTILBENE; RAS PROTEIN; STILBENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOFILM EFFECT; ANTIFUNGAL ACTIVITY; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BIOFILM; CANDIDA ALBICANS; CATHETER INFECTION; CELL SURFACE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; FEMALE; FUNGAL CELL; FUNGAL STRAIN; FUNGICIDAL ACTIVITY; GENE EXPRESSION; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN UNFOLDING; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; UPREGULATION;

ANIMALS; ANTIFUNGAL AGENTS; BIOFILMS; CANDIDA ALBICANS; FEMALE; FUNGAL PROTEINS; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, SCANNING; RATS; RATS, SPRAGUE-DAWLEY; STILBENES;

EID: 84896938952     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01583-13     Document Type: Article

References (71)

1. Karkowska-Kuleta J, Rapala-Kozik M, Kozik A. 2009. Fungi pathogenic to humans: molecular bases of virulence of Candida albicans, Cryptococcus neoformans and Aspergillus fumigatus. Acta Biochim. Pol. 56:211-224.
2. Alangaden GJ. 2011. Nosocomial fungal infections: epidemiology, infection control, and prevention. Infect. Dis. Clin. North Am. 25:201-225. http://dx.doi.org/10.1016/j.idc.2010.11.003.
3. Jarvis WR. 1995. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin. Infect. Dis. 20:1526-1530.
4. Miceli MH, Lee SA. 2011. Emerging moulds: epidemiological trends and antifungal resistance. Mycoses 54:e666-e678. http://dx.doi.org/10.1111/j.1439- 0507.2011.02032.x.
5. Donlan RM, Costerton JW. 2002. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin. Microbiol. Rev. 15:167-193. http://dx.doi.org/10.1128/CMR.15.2.167-193.2002. (Pubitemid 34303762)
6. Chandra J, Mukherjee PK, Leidich SD, Faddoul FF, Hoyer LL, Douglas LJ, Ghannoum MA. 2001. Antifungal resistance of Candidal biofilms formed on denture acrylic in vitro. J. Dent. Res. 80:903-908. http://dx.doi.org/10.1177/ 00220345010800031101. (Pubitemid 32477425)
7. Ramage G, Vandewalle K, Wickes BL, Lopez-Ribot JL. 2001. Characteristics of biofilm formation by Candida albicans. Rev. Iberoam. Micol. 18:163-170. (Pubitemid 34116636)
8. Berman J, Sudbery PE. 2002. Candida albicans: a molecular revolution built on lessons from budding yeast. Nat. Rev. Genet. 3:918-930. http://dx.doi.org/10.1038/nrg948. (Pubitemid 35423504)
9. Pukkila-Worley R, Peleg AY, Tampakakis E, Mylonakis E. 2009. Candida albicans hyphal formation and virulence assessed using a Caenorhabditis elegans infection model. Eukaryot. Cell 8:1750-1758. http://dx.doi.org/10.1128/EC.00163- 09.
10. Sobolev VS, Cole RJ, Dorner JW, Yagen B. 1995. Isolation, purification, and liquid chromatographic determination of stilbene phytoalexins in peanuts. J. AOAC Int. 78:1177-1182.
11. Langcake P, Cornford CA, Pryce RJ. 1979. Identification of pterostilbene as aphytoalexin from Vitis vinifera leaves. Phytochemistry 18:1025-1027.
12. Seshadri TR. 1972. Polyphenols of Pterocarpus and Dalbergia woods. Phytochemistry 11:881-898.
13. Rimando AM, Kalt W, Magee JB, Dewey J, Ballington JR. 2004. Resveratrol, pterostilbene, and piceatannol in vaccinium berries. J. Agric. Food Chem. 52:4713-4719. http://dx.doi.org/10.1021/jf040095e.
14. Cichocki M, Paluszczak J, Szaefer H, Piechowiak A, Rimando AM, Baer-Dubowska W. 2008. Pterostilbene is equally potent as resveratrol in inhibiting 12-O-tetradecanoylphorbol-13-acetate activated NFκB, AP-1, COX-2, and iNOS in mouse epidermis. Mol. Nutr. Food Res. 52(Suppl 1):S62-S70. http://dx.doi.org/10.1002/mnfr.200700466.
15. McCormack D, Schneider J, McDonald D, McFadden D. 2011. The antiproliferative effects of pterostilbene on breast cancer in vitro are via inhibition of constitutive and leptin-induced Janus kinase/signal transducer and activator of transcription activation. Am. J. Surg. 202:541-544. http://dx.doi.org/10.1016/j.amjsurg.2011.06.020.
16. Wang Y, Ding L, Wang X, Zhang J, Han W, Feng L, Sun J, Jin H, Wang XJ. 2012. Pterostilbene simultaneously induces apoptosis, cell cycle arrest and cyto-protective autophagy in breast cancer cells. Am. J. Transl. Res. 4:44-51.
17. Remsberg CM, Yanez JA, Ohgami Y, Vega-Villa KR, Rimando AM, Davies NM. 2008. Pharmacometrics of pterostilbene: preclinical pharmacokinetics and metabolism, anticancer, antiinflammatory, antioxidant and analgesic activity. Phytother. Res. 22:169-179. http://dx.doi.org/10.1002/ptr.2277. (Pubitemid 351363234)
18. Sobolev VS, Khan SI, Tabanca N, Wedge DE, Manly SP, Cutler SJ, Coy MR, Becnel JJ, Neff SA, Gloer JB. 2011. Biological activity of peanut (Arachis hypogaea) phytoalexins and selected natural and synthetic stilbenoids. J. Agric. Food Chem. 59:1673-1682. http://dx.doi.org/10.1021/jf104742n.
19. Pont V, Pezet R. 1990. Relation between the chemical structure and the biological activity of hydroxystilbenes against Botrytis cinerea. J. Phytopathol. 130:1-8.
20. Adrian M, Jeandet P, Veneau J, Weston LA, Bessis R. 1997. Biological activity of resveratrol, a stilbenic compound from grapevines, against Botrytis cinerea, the causal agent for gray mold. J. Chem. Ecol. 23:1689-1702. (Pubitemid 27347638)
21. Zou Y, Huang Q, Huang TK, Ni QC, Zhang ES, Xu TL, Yuan M, Li J. 2013. CuI/1,10-phen/PEG promoted decarboxylation of 2,3-diarylacrylic acids: synthesis of stilbenes under neutral and microwave conditions with an in situ generated recyclable catalyst. Org. Biomol. Chem. 11:6967-6974. http://dx.doi.org/10.1039/ c3ob41588k.
22. Lin HS, Yue BD, Ho PC. 2009. Determination of pterostilbene in rat plasma by a simple HPLC-UV method and its application in pre-clinical pharmacokinetic study. Biomed. Chromatogr. 23:1308-1315. http://dx.doi.org/10.1002/bmc.1254.
23. Maidan MM, De Rop L, Serneels J, Exler S, Rupp S, Tournu H, Thevelein JM, Van Dijck P. 2005. The G protein-coupled receptor Gpr1 and the Gα protein Gpa2 act through the cAMP-protein kinase A pathway to induce morphogenesis in Candida albicans. Mol. Biol. Cell 16:1971-1986. http://dx.doi.org/10.1091/mbc. E04-09-0780. (Pubitemid 40471964)
24. Lee KL, Buckley HR, Campbell CC. 1975. An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida albicans. Sabouraudia 13:148-153.
25. Gimeno CJ, Ljungdahl PO, Styles CA, Fink GR. 1992. Unipolar cell divisions in the yeast S. cerevisiae lead to filamentous growth: regulation by starvation and RAS. Cell 68:1077-1090.
26. CLSI. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts, vol 28, no. 14. Approved standard, 3rd ed. CLSI document M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA.
27. An M, Shen H, Cao Y, Zhang J, Cai Y, Wang R, Jiang Y. 2009. Allicin enhances the oxidative damage effect of amphotericin B against Candida albicans. Int. J. Antimicrob. Agents 33:258-263. http://dx.doi.org/10.1016/j.ijantimicag. 2008.09.014.
28. Quan H, Cao YY, Xu Z, Zhao JX, Gao PH, Qin XF, Jiang YY. 2006. Potent in vitro synergism of fluconazole and berberine chloride against clinical isolates of Candida albicans resistant to fluconazole. Antimicrob. Agents Chemother. 50:1096-1099. http://dx.doi.org/10.1128/AAC.50.3.1096-1099.2006. (Pubitemid 43327820)
29. Xu Y, Wang Y, Yan L, Liang RM, Dai BD, Tang RJ, Gao PH, Jiang YY. 2009. Proteomic analysis reveals a synergistic mechanism of fluconazole and berberine against fluconazole-resistant Candida albicans: endogenous ROS augmentation. J. Proteome Res. 8:5296-5304. http://dx.doi.org/10.1021/pr9005074.
30. Ramage G, Saville SP, Wickes BL, Lopez-Ribot JL. 2002. Inhibition of Candida albicans biofilm formation by farnesol, a quorum-sensing molecule. Appl. Environ. Microbiol. 68:5459-5463. http://dx.doi.org/10.1128/AEM.68.11.5459- 5463.2002. (Pubitemid 35265681)
31. Klotz SA, Drutz DJ, Zajic JE. 1985. Factors governing adherence of Candida species to plastic surfaces. Infect. Immun. 50:97-101. (Pubitemid 15239194)
32. Nobile CJ, Andes DR, Nett JE, Smith FJ, Yue F, Phan QT, Edwards JE, Filler SG, Mitchell AP. 2006. Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. PLoS Pathog. 2(7):e63. http://dx.doi.org/10.1371/journal.ppat.0020063.
33. Cao Y, Dai B, Wang Y, Huang S, Xu Y, Gao P, Zhu Z, Jiang Y. 2008. In vitro activity of baicalein against Candida albicans biofilms. Int. J. Antimicrob. Agents 32:73-77. http://dx.doi.org/10.1016/j.ijantimicag.2008.01. 026.
34. Braga PC, Culici M, Alfieri M, Dal Sasso M. 2008. Thymol inhibits Candida albicans biofilm formation and mature biofilm. Int. J. Antimicrob. Agents 31:472-477. http://dx.doi.org/10.1016/j.ijantimicag.2007.12.013.
35. Köhrer K, Domdey H. 1991. Preparation of high molecular weight RNA. Methods Enzymol. 194:398-405.
36. Patterson TA, Lobenhofer EK, Fulmer-Smentek SB, Collins PJ, Chu TM, Bao W, Fang H, Kawasaki ES, Hager J, Tikhonova IR. 2006. Performance comparison of one-color and two-color platforms within the MicroArray Quality Control (MAQC) Project. Nat. Biotechnol. 24: 1140-1150. http://dx.doi.org/10.1038/nbt1242.
37. Guo Y, Guo H, Zhang L, Xie H, Zhao X, Wang F, Li Z, Wang Y, Ma S, Tao J, Wang W, Zhou Y, Yang W, Cheng J. 2005. Genomic analysis of anti-hepatitis B virus (HBV) activity by small interfering RNA and lamivudine in stable HBV-producing cells. J. Virol. 79:14392-14403. http://dx.doi.org/10.1128/JVI.79. 22.14392-14403.2005. (Pubitemid 41552736)
38. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, Speed TP. 2002. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30:e15. http://dx.doi.org/10.1093/nar/30.4.e15.
39. Boyle EI, Weng S, Gollub J, Jin H, Botstein D, Cherry JM, Sherlock G. 2004. GO::TermFinder - open source software for accessing Gene Ontology information and finding significantly enriched Gene Ontology terms associated with a list of genes. Bioinformatics 20:3710-3715. http://dx.doi.org/10.1093/ bioinformatics/bth456. (Pubitemid 40136825)
40. Li DD, Wang Y, Dai BD, Li XX, Zhao LX, Cao YB, Yan L, Jiang YY. 2013. ECM17-dependent methionine/cysteine biosynthesis contributes to biofilm formation in Candida albicans. Fungal Genet. Biol. 51:50-59. http://dx.doi.org/10.1016/j.fgb.2012.11.010.
41. Andes D, Nett J, Oschel P, Albrecht R, Marchillo K, Pitula A. 2004. Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect. Immun. 72:6023-6031. http://dx.doi.org/10.1128/ IAI.72.10.6023-6031.2004. (Pubitemid 39303717)
42. Seneviratne CJ, Jin L, Samaranayake LP. 2008. Biofilm lifestyle of Candida: a mini review. Oral Dis. 14:582-590. http://dx.doi.org/10.1111/j.1601- 0825.2007.01424.x.
43. Luo G, Samaranayake LP. 2002. Candida glabrata, an emerging fungal pathogen, exhibits superior relative cell surface hydrophobicity and adhesion to denture acrylic surfaces compared with Candida albicans. APMIS 110:601-610. http://dx.doi.org/10.1034/j.1600-0463.2002.1100902.x. (Pubitemid 35335128)
44. Pompilio A, Piccolomini R, Picciani C, D'Antonio D, Savini V, Di Bonaventura G. 2008. Factors associated with adherence to and biofilm formation on polystyrene by Stenotrophomonas maltophilia: the role of cell surface hydrophobicity and motility. FEMS Microbiol. Lett. 287:41-47. http://dx.doi.org/10.1111/j.1574-6968.2008.01292.x.
45. Samaranayake YH, Wu PC, Samaranayake LP, So M. 1995. Relationship between the cell surface hydrophobicity and adherence of Candida krusei and Candida albicans to epithelial and denture acrylic surfaces. APMIS 103:707-713.
46. Zhu Y, Fang HM, Wang YM, Zeng GS, Zheng XD, Wang Y. 2009. Ras1 and Ras2 play antagonistic roles in regulating cellular cAMP level, stationary-phase entry and stress response in Candida albicans. Mol. Microbiol. 74:862-875. http://dx.doi.org/10.1111/j.1365-2958.2009.06898.x.
47. Birse CE, Irwin MY, Fonzi WA, Sypherd PS. 1993. Cloning and characterization of ECE1, a gene expressed in association with cell elongation of the dimorphic pathogen Candida albicans. Infect. Immun. 61:3648-3655. (Pubitemid 23260033)
48. Beggah S, Lechenne B, Reichard U, Foundling S, Monod M. 2000. Intraand intermolecular events direct the propeptide-mediated maturation of the Candida albicans secreted aspartic proteinase Sap1p. Microbiology 146:2765-2773.
49. Urban C, Sohn K, Lottspeich F, Brunner H, Rupp S. 2003. Identification of cell surface determinants in Candida albicans reveals Tsa1p, a protein differentially localized in the cell. FEBS Lett. 544:228-235. http://dx.doi.org/10.1016/S0014-5793(03)00455-1. (Pubitemid 36628068)
50. Uhl MA, Biery M, Craig N, Johnson AD. 2003. Haploinsufficiency-based large-scale forward genetic analysis of filamentous growth in the diploid human fungal pathogen C. albicans. EMBO J. 22:2668-2678. http://dx.doi.org/10.1093/ emboj/cdg256. (Pubitemid 36712364)
51. Granger BL, Flenniken ML, Davis DA, Mitchell AP, Cutler JE. 2005. Yeast wall protein 1 of Candida albicans. Microbiology 151:1631-1644. http://dx.doi.org/10.1099/mic.0.27663-0. (Pubitemid 40711808)
52. Sudbery PE. 2011. Growth of Candida albicans hyphae. Nat. Rev. Microbiol. 9:737-748. http://dx.doi.org/10.1038/nrmicro2636.
53. Chaffin WL. 2008. Candida albicans cell wall proteins. Microbiol. Mol. Biol. Rev. 72:495-544. http://dx.doi.org/10.1128/MMBR.00032-07.
54. Braun BR, Johnson AD. 2000. TUP1, CPH1 and EFG1 make independent contributions to filamentation in Candida albicans. Genetics 155:57-67. (Pubitemid 30257110)
55. Hogan DA, Sundstrom P. 2009. The Ras/cAMP/PKA signaling pathway and virulence in Candida albicans. Future Microbiol. 4:1263-1270. http://dx.doi.org/10.2217/fmb.09.106.
56. Vila TV, Ishida K, de Souza W, Prousis K, Calogeropoulou T, Rozental S. 2013. Effect of alkylphospholipids on Candida albicans biofilm formation and maturation. J. Antimicrob. Chemother. 68:113-125. http://dx.doi.org/10.1093/jac/ dks353.
57. Okamoto-Shibayama K, Sato Y, Azuma T. 2010. Resveratrol impaired the morphological transition of Candida albicans under various hyphae-inducing conditions. J. Microbiol. Biotechnol. 20:942-945.
58. Collado-Gonzalez M, Guirao-Abad JP, Sanchez-Fresneda R, Belchi-Navarro S, Arguelles JC. 2012. Resveratrol lacks antifungal activity against Candida albicans. World J. Microbiol. Biotechnol. 28:2441-2446. http://dx.doi.org/10. 1007/s11274-012-1042-1.
59. Weber K, Schulz B, Ruhnke M. 2011. Resveratrol and its antifungal activity against Candida species. Mycoses 54:30-33. http://dx.doi.org/10.1111/j. 1439-0507.2009.01763.x.
60. Nobile CJ, Mitchell AP. 2006. Genetics and genomics of Candida albicans biofilm formation. Cell. Microbiol. 8:1382-1391. http://dx.doi.org/10.1111/j. 1462-5822.2006.00761.x. (Pubitemid 44194572)
61. Ramage G, Saville SP, Thomas DP, Lopez-Ribot JL. 2005. Candida biofilms: an update. Eukaryot. Cell 4:633-638. http://dx.doi.org/10.1128/EC.4.4.633-638. 2005. (Pubitemid 40600417)
62. Sundstrom P. 2002. Adhesion in Candida spp. Cell. Microbiol. 4:461-469. http://dx.doi.org/10.1046/j.1462-5822.2002.00206.x. (Pubitemid 34993745)
63. Tronchin G, Pihet M, Lopes-Bezerra LM, Bouchara JP. 2008. Adherence mechanisms in human pathogenic fungi. Med. Mycol. 46:749-772. http://dx.doi.org/10.1080/136937802206435.
64. Zheng X, Wang Y. 2004. Hgc1, a novel hypha-specific G1 cyclin-related protein regulates Candida albicans hyphal morphogenesis. EMBO J. 23: 1845-1856. http://dx.doi.org/10.1038/sj.emboj.7600195. (Pubitemid 38649647)
65. Nett JE, Lepak AJ, Marchillo K, Andes DR. 2009. Time course global gene expression analysis of an in vivo Candida biofilm. J. Infect. Dis. 200: 307-313. http://dx.doi.org/10.1086/599838.
66. Rajput SB, Karuppayil SM. 2013. β-Asarone, an active principle of Acorus calamus rhizome, inhibits morphogenesis, biofilm formation and ergosterol biosynthesis in Candida albicans. Phytomedicine 20:139-142. http://dx.doi.org/10.1016/j.phymed.2012.09.029.
67. Burnie JP, Carter TL, Hodgetts SJ, Matthews RC. 2006. Fungal heatshock proteins in human disease. FEMS Microbiol. Rev. 30:53-88. http://dx.doi.org/10. 1111/j.1574-6976.2005.00001.x.
68. Pan Z, Agarwal AK, Xu T, Feng Q, Baerson SR, Duke SO, Rimando AM. 2008. Identification of molecular pathways affected by pterostilbene, a natural dimethylether analog of resveratrol. BMC Med. Genomics 1:7. http://dx.doi.org/ 10.1186/1755-8794-1-7.
69. Bahn YS, Molenda M, Staab JF, Lyman CA, Gordon LJ, Sundstrom P. 2007. Genome-wide transcriptional profiling of the cyclic AMP-dependent signaling pathway during morphogenic transitions of Candida albicans. Eukaryot. Cell 6:2376-2390. http://dx.doi.org/10.1128/EC.00318-07.
70. Kapetanovic IM, Muzzio M, Huang Z, Thompson TN, McCormick DL. 2011. Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemother. Pharmacol. 68:593-601. http://dx.doi.org/10.1007/s00280-010-1525-4.
71. Ruiz MJ, Fernandez M, Pico Y, Manes J, Asensi M, Carda C, Asensio G, Estrela JM. 2009. Dietary administration of high doses of pterostilbene and quercetin to mice is not toxic. J. Agric. Food Chem. 57:3180-3186. http://dx.doi.org/10.1021/jf803579e.